Worries Around Sinopharm Resurface Following Low Antibody Tests
Worries around the Chinese Sinopharm vaccine have resurfaced after insufficient antibody levels were recorded in many people who received both vaccinations in Hungary. While those who defend the vaccine assert that people can still have cell immunity, there is increasing evidence that this is not the case. Those wishing to raise awareness on the issue have joined a Facebook group, sending letters to Prime Minister Viktor Orbán, Chief Medical Officer Cecília Müller, and Hungarian healthcare professionals.
There are more than 3.6 thousand members in the rapidly growing “People Vaccinated with Sinopharm with Negative Laboratory Tests,” closed Facebook group. The purpose of the group is to ensure testing and revaccination if necessary for people who have been vaccinated with the Sinopharm vaccine but have little to no antibodies in their immune system.
Hungary Prepares for Ten-Day Sinopharm Vaccination Campaign
Hungary is initiating a ten-day mass vaccination program next week, as one million doses of the Chinese Sinopharm vaccine will be arriving. A letter from the National Health Insurance Fund (NEAK) and another from state secretary and leader of Hungary’s vaccination workforce István György was sent to general practitioners, informing them of the massive undertaking. While the government is trying out a new system for organizing Hungary’s vaccination campaign, many doctors are worried that their patients will not be willing to accept Sinopharm.
Minister of Foreign Affairs and Trade Péter Szijjártó announced on Saturday that instead of the expected 400 thousand doses, one million doses of the Chinese vaccine will arrive in Hungary by the end of April. In order to prepare for this, the government is ensuring that all currently available vaccines be put to use before the ambitious vaccination program begins.